Breaking News, Financial News

Financial Report: AMRI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI

2Q Revenues: $49.4 million (+8%)

2Q Earnings: $4.6 million (loss of $353,000 in 2Q2006)*

YTD Revenues: $97.7 million (+10%)

YTD Earnings: $7.8 million (earnings were $1.5 million YTD2006)

Comments: Contract revenue in the quarter was $39.9 million, up 4%. Contract revenue from development and small-scale manufacturing was $10.6 million, up 25%, while large-scale manufacturing revenue was down 5% to $19.6 million. Revenue from discovery services in the quarter was $9.7 million, up 6%. YTD development and small-scale manufacturing revenues were $20.9 million, up 21% and YTD large-scale manufacturing revenues were $40.7 million, up 2%.

*2Q2006 earnings included charges of $2.2 million to reduce the carrying value of the company’s former Mount Prospect Research Center.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters